Our coverage of cagrilintide for weight loss , cagrilintide for men , cagrilintide dosing , CagriSema dosing , and the amylin receptor agonist mechanism provides the full picture
Dimple Gandhi kicked off the series July 8, 2022 in episode 160
Semaglutide, the blockbuster GLP-1 receptor agonist marketed under names like Ozempic (type 2 diabetes) and Wegovy (weight loss), has rapidly become one of the most consequential drugs in modern healthcare
However, it's important to note that while these effects are promising, GLP-1 receptor agonists are not currently licensed specifically for treating liver conditions in the UK
Aside from the major dent in your wallet, GLP-1s have many serious (and possibly long-term) negative consequences
Thats the basis for our recommendations